Desonide Ointment
Product Images NDC 45802-423

3 FDA label images from Padagis Israel Pharmaceuticals Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Desonide (NDC 45802-423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Perrigo Desonide Ointment (Image 01)

Perrigo Desonide Ointment (Image 01)
Chemical structure diagram of desonide, showing its steroid backbone with multiple rings, hydroxyl group, ketone group, and ester functional groups.*
FDA Label Image

Carton (Carton)

Carton (Carton)
Label for Desonide Ointment 0.05%, topical ointment, with a net weight of 15 g. The label includes dosing and storage instructions, and states the ointment contains 0.5 mg/g desonide in white petrolatum. The product is manufactured by Padagis in Italy and distributed by Padagis Israel Pharmaceuticals Ltd. The label prominently displays the Padagis logo and NDC 45802-423-35.*
FDA Label Image

Serialization-template.jpg (Serialization Template)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.